NASDAQ:QGEN
Qiagen N.V. Stock News
$40.00
+0.530 (+1.34%)
At Close: Apr 19, 2024
QIAGEN N.V. to release results for Q1 2024 and hold webcast
09:48am, Tuesday, 09'th Apr 2024
Venlo, The Netherlands, April 09, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the first quarter 2024.
QIAGEN (QGEN) Boosts Cancer Research Suite With New Launches
02:26pm, Thursday, 04'th Apr 2024
QIAGEN's (QGEN) new products, coupled with the IVD version of QIAGEN's digital PCR platform QIAcuity, are planned to be released in mid-2024.
QIAGEN (QGEN) Unveils QIAstat-Dx Analyzer With Remote Access
11:11am, Tuesday, 26'th Mar 2024
With QIAGEN's (QGEN) QIAstat-Dx Analyzer 2.0's integration of remote access, central and regional laboratories may work together efficiently, particularly when it comes to decentralized testing.
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
10:10am, Monday, 25'th Mar 2024
QIAGEN's (QGEN) collaboration with IPPA follows the updated CDC guidelines for TB screening for immigrants in the United States.
Qiagen (QGEN) Up 1.1% Since Last Earnings Report: Can It Continue?
12:36pm, Thursday, 07'th Mar 2024
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock?
QIAGEN (QGEN) Launches AI-Driven Biomedical Knowledge Base
09:41am, Monday, 04'th Mar 2024
QIAGEN (QGEN) introduces a Biomedical KB-AI knowledge base to accelerate data-driven drug discovery.
QIAGEN (QGEN) Earns Notable Recognitions in Sustainability
10:10am, Monday, 19'th Feb 2024
QIAGEN (QGEN) achieves the ACT Label for new eco-friendly QIAwave products and the first My Green Lab Platinum certification.
Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript
04:55am, Sunday, 11'th Feb 2024
Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript
QIAGEN (QGEN) Q4 Earnings Miss, Operating Margin Expands
08:21am, Wednesday, 07'th Feb 2024
QIAGEN's (QGEN) fourth-quarter performance reflects impressive CER sales growth and solid profitability.
Qiagen (QGEN) Reports Q4 Earnings: What Key Metrics Have to Say
09:01pm, Tuesday, 06'th Feb 2024
Although the revenue and EPS for Qiagen (QGEN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Stree
QIAGEN (QGEN) Forges Alliance to Advance Microbiome Sciences
08:36am, Wednesday, 31'st Jan 2024
QIAGEN (QGEN) announces a first-in-kind collaboration with Penn State University to help shape research, education and outreach in microbiomes.
QIAGEN (QGEN) Wins FDA Clearance for NeuMoDx CT/NG Assay
09:47am, Friday, 12'th Jan 2024
QIAGEN (QGEN) receives FDA clearance for the NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 versions of the integrated PCR-based clinical molecular testing system.
QIAGEN N.V. to release results for Q4 2023 and hold webcast
07:53am, Thursday, 11'th Jan 2024
Venlo, The Netherlands, Jan. 11, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.
QIAGEN (QGEN) Gains From New Alliances Amid FX Headwind
12:02pm, Tuesday, 09'th Jan 2024
QIAGEN (QGEN) is progressing well with its testing menu expansion strategy, which is driving the company's growth.
Here's Why You Should Retain QIAGEN (QGEN) Stock for Now
09:01am, Thursday, 28'th Dec 2023
Investors remain optimistic about QIAGEN (QGEN), backed by strategic alliances and potential in the Molecular Diagnostics arena.
